Discussion: Evaluating the Efficacy of Treatment, Follow-Up Outcomes, and Recurrence Trends in Pediatric Helicobacter pylori Infections
-
By
-
Toshihiko Kakiuchi
-
September 3, 2026
By
Toshihiko Kakiuchi
September 3, 2026
by Toshihiko Kakiuchi
September 3, 2026
First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.
August 31, 2026
Greater glucose fluctuations but not HbA1c were associated with neuroretinal alterations over 3 years in pediatric patients with type 1 diabetes.
September 1, 2026